Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice
- 264 Downloads
Kava has been used for centuries by Pacific Islanders for its tranquilizing and sedative effects. Recent clinical trials suggest that kava has therapeutic value for the treatment of anxiety. Demonstration of kava's anxiolytic effects in animals under controlled conditions would provide additional support for its clinical potential as an anxiolytic and would facilitate investigation of its mechanism(s) of action.
This study systematically characterized the acute dosage-dependent anxiolytic and sedative effects of kava extract in well established quantitative murine behavioral assays and compared kava- and diazepam-induced behavioral changes.
Various doses of an ethanolic extract of kava root or diazepam were administered intraperitoneally to BALB/cByJ inbred mice. Behavioral changes were measured in the mirrored chamber avoidance assay and elevated plus-maze assay. Reduced latency to enter and increased time spent in a normally avoided environment operationally defined anxiolysis. Sedation was defined by a significant decrease in locomotor activity in a circular arena.
Kava extract produced statistically significant dose-dependent anxiolytic-like behavioral changes in both assays of anxiolysis. ED50 values for kava-induced increases in time spent inside the mirrored chamber and on the open arms of the plus maze were 125 mg/kg and 88 mg/kg, respectively. Kava extract also caused a profound decrease in locomotor activity (ED50 of 172 mg/kg). Flumazenil, a competitive benzodiazepine receptor antagonist, blocked both the anxiolytic and sedative effects of diazepam, but had no effect on kava's behavioral actions.
Kava extracts produce significant murine anxiolytic-like behavioral changes and sedation that are not mediated through the benzodiazepine binding site on the GABAA receptor complex.
KeywordsKava Anxiety Sedation Mice Benzodiazepines
This work was supported by a grant from the Presbyterian Health Foundation.
- Darragh A, Lambe R, Kenny M, Brick I, Taaffe W, O'Boyle C (1982) RO 15-1788 antagonizes the central effects of diazepam in man without altering diazepam bioavailability. Br J Clin Pharmacol 14:677–682Google Scholar
- Duffield AM, Lidgard RO (1986) Analysis of kava resin by gas chromatography and electron impact and methane negative ion chemical ionization mass spectrometry. Biomed Mass Spectrom 13:621–626Google Scholar
- Duffield AM, Lidgard RO, Low GK-C (1986) Analysis of the constituents of Piper methysticum by gas chromatography methane chemical ionization mass spectrometry. Biomed Mass Spectrom 13:303–313Google Scholar
- Ganzera M, Khan IA (1999) Analytical techniques for determination of lactones in Piper methysticum Forst. Chromatographia 50:649–653Google Scholar
- Garrett KM, Niekrasz I, Haque D, Parker KM, Seale TW (1998) Genotypic differences between C57BL/6 and A inbred mice in anxiolytic and sedative actions of diazepam. Behav Genet 28:125–136Google Scholar
- Handley SL, Mithani S (1984) Effects of alpha-adrenoreceptor agonists and antagonists in a maze exploration model of "fear"-motivated behavior. Naunyn-Schmiedeberg's Arch Pharmacol 327:1–5Google Scholar
- Houri D (1986) Effects of central acting drugs on the mirror staircase test. Nippon Yaturigaku Zasshi 87:135–142Google Scholar
- Keller K, Klohs MW (1963) A review of the chemistry and pharmacology of the constituents of Piper methysticum. Lloydia 26:1–15Google Scholar
- National Institutes of Health (1996) Guide for the Care and Use of Laboratory Animals. National Academies PressGoogle Scholar
- Montgomery KC (1958) The relation between fear induced by novel; stimulation and exploratory behavior. J Comp Physiol Psychol 48:254–260Google Scholar
- Pittler MH, Ernst E (2000) Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J Clin Psychopharmacol 20:84–89Google Scholar
- Seale TW, Garrett KM (1995) Genotype-dependent heterogeneity in basal activity and benzodiazepine-induced alteration in anxiety-like behaviors. Behav Genet 25:287Google Scholar
- Shulgin AT (1973) The narcotic pepper—the chemistry and pharmacology of Piper methysticum and related species. Bull Narc 25:59–74Google Scholar
- Vogel JR, Beer B, Clody DE (1971) A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21:1–7Google Scholar